- Terbinafine inhibits KSR1 and suppresses Raf-MEK-ERK signaling in ora…
Number of the records: 1  

Terbinafine inhibits KSR1 and suppresses Raf-MEK-ERK signaling in oral squamous cell carcinoma cells

  1. SYS0094287
    LBL
      
    00000naa--2200000-a-4500
    005
      
    20250607150342.5
    008
      
    140205c2013----xo-----e------------eng--
    040
      
    $a BA006 $b slo
    041
    0-
    $a eng $b eng
    044
      
    $a xo $c SK
    242
    10
    $a Terbinafín inhibuje KSR1 a potláča Raf-MEK-ERK signalizáciu v skvamóznych bunkách karcinómu ústnej dutiny $y slo
    245
    10
    $a Terbinafine inhibits KSR1 and suppresses Raf-MEK-ERK signaling in oral squamous cell carcinoma cells / $c B. Li ... [et al.]
    300
      
    $b ilustr. (aj fareb.), fotogr., grafy, obr., tab.
    504
      
    $a Bibliogr. odkazy
    504
      
    $a Res. angl.
    650
    12
    $7 sllk_us_auth*d009062 $a nádory ústnej dutiny $x farmakoterapia $x patológia $2 mesh
    650
    12
    $7 sllk_us_auth*d002294 $a karcinóm skvamocelulárny $x farmakoterapia $x patológia $2 mesh
    650
    12
    $7 sllk_us_auth*d000935 $a antimykotiká $x použitie terapeutické $2 mesh
    650
    22
    $7 sllk_us_auth*d048049 $a MAP kinázy regulované extracelulárnym signálom $2 mesh
    650
    22
    $7 sllk_us_auth*d011494 $a proteínkinázy $2 mesh
    650
    22
    $7 sllk_us_auth*d017209 $a apoptóza $2 mesh
    650
    22
    $7 sllk_us_auth*d007624 $a bunky KB $2 mesh
    650
    22
    $7 sllk_us_auth*d013534 $a prežívanie $2 mesh
    653
    2-
    $a terbinafín
    653
    2-
    $a KSR1 proteín
    700
    1-
    $7 sllk_us_auth*0031362 $a Li, B. $u China Medical University, Shenyang, China $4 aut
    773
    0-
    $7 nnas $w sllk_us_cat*0087296 $t Neoplasma $f Cancer Research Institute of the Slovak Academy of Sciences $x 0028-2685 $d Bratislava : AEPress, 2013 $g Vol. 60, no. 4 (2013), s. 406-412
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.